Plaintiffs BRFHH Shreveport, LLC (“BRFHH”), and Vantage Health Plan, Inc. (“Vantage”), a healthcare provider and a healthcare insurer respectively, allege that past and present acquisitions by the Defendant, also a healthcare provider, in Shreveport and Bossier ■ City, Louisiana, violate federal antitrust laws. Before the Court is the Defendant’s Motion To Dismiss, [Record Document 30], limited at this stage in the litigation to the question of whether Federal Rule of Civil Procedure 12(b)(6) requires dismissal of Plaintiff Vantage Health Plan Inc.’s federal monopolization claims, Record Document 83. The parties have extensively briefed this question, together 'filing three memorandums on the initial, broader dismissal arguments raised by the Defendant, Record Documents 30, 65, 75, and four memorandums on the narrower dismissal issue now before the Court, Record Documents 89, 90, 93, 97. After consideration of the foregoing, the Court hereby DENIES the Defendant’s motion.
I. Background
A. The Parties
Plaintiff BRFHH Shreveport, LLC, is the operator of University Health Hospital (“University Health”) in Shreveport. Once a state-owned and -operated charity hospital, University Health has been operated by BRFHH Shreveport since September of 2013, when Louisiana State University (“LSU”), whose neighboring medical school has traditionally supplied physicians for University Hospital, and the parent entities of BRFHH Shreveport signed a Cooperative Endeavor Agreement transferring hospital management authority from the state of Louisiana to BRFHH Shreveport’s parent entity. Record - Documents 49, p. 3, and 77-1, p. 89. The privatization effected by the 2013 agreement, however, is not unbounded: under the terms of the 2013 agreement, University Hospital continues to depend exclusively on admissions from LSU physicians and treat a substantial portion of the Shreveport area’s indigent population. Record Document 1, p. 6, 8. According to BRFHH Shreveport, sustaining these mandates while remaining financially viable requires that a critical,..if minority, mqss of.the patients treated, at University Health- have private,. commercial insurance; the higher reimbursement rates associated with commercial insurance help offset the relatively low profitability of treating the indigent. Id. at 8. Vantage Health Plan, Inc., is a health insurance provider specializing in lower-cost HMO coverage. Id. at 6, 18. Vantage is headquartered in Monroe, Louisiana, where the large majority of its, 35,-000 subscribers reside. Id. at p. 6, 18, 43. Defendant Willis-Knighton Medical Center (“Willis-Knighton”) is a competing healthcare provider that operates four hospitals and at least six free-standing clinics in Shreveport and Bossier City. Record Document 48, p. 39. University Health participates in Vantage’s Tier-1 network; Willis-Knighton does not. Id. at 18. .
B. Relevant Geographic Market
According to the Plaintiffs, Shreveport and Bossier City (the “Shreveport area”) together form the relevant geographic market in which Defendant’s antitrust violations occurred and will occur. Id. at 43. Within the Shreveport area there are three entities that operate hospitals: Willis-Knighton, BRFHH Shreveport, and CHRISTUS Health Northern Louisiana (“CHRISTUS”). Id. at 7. According to the Plaintiffs, Willis-Knighton’s share of hospital admissions in the Shreveport area is approximately 60% overall and approximately 75% among commercially insured
C. Plaintiffs' Claims
1. Past Conduct
BRFHH Shreveport and Vantage describe two sets of antitrust claims. The first set is about prior conduct: Vantage— and Vantage alone — asserts that some of Willis-Knighton’s prior acquisitions, physician referral practices, and non-compete employment contracts violated section 2 of the Sherman Act, which prohibits monopolization and attempted monopolization, and section 7 of the Clayton Act, which prohibits anticompetitive acquisitions and mergers. Id. at 10,15-21, 74-76. From Vantage’s perspective, this prior-conduct theory of liability explains how Willis-Knighton has historically violated antitrust laws to exclude Vantage from participating in the Shreveport area healthcare insurance market and why Vantage is therefore entitled to recover damages. It proceeds in four parts.
First, at some point in the last fifteen years, Willis-Knighton allegedly gained monopoly power in the Shreveport area in at least the markets for general acute-care hospital services, adult primary care, and Obstetrics/Gynecology (“Ob/Gyn”). Id. at 10, 74. As broad evidence of this ascent, the complaint states that since 2000, Willis-Knighton has enjoyed a sevenfold increase in the number of physicians it employs and a fivefold increase in revenues.
Second, over this same period, and while it had monopoly power, Willis-Knighton is alleged to have engaged in various anti-competitive acts in the Shreveport area to gain or maintain the monopolies described above. Some of these anticompetitive acts were acquisitions of rival healthcare providers. Specifically, the complaint alleges Willis-Knighton acquired the following five providers: Bossier Medical Center, Doctor’s Hospital, CHRISTUS’s acute-care services, the Northwest Louisiana Surgery Hospital, and “a previously independent cardiology group.” Id. at 5-6, 10, 17. With respect to the acquisitions of Bossier Medical Center, Doctor’s Hospital, and CHRISTUS’s acute care services, the complaint describes a type of multi-step acquisition in which first Willis-Knighton acquired physicians from the competing provider, then the competing provider failed, and finally, in two (unidentified) instances, Willis-Knighton purchased the remaining physical assets of the shuttered entities. Id. at 5-6. According to the complaint, the closure of CHRISTUS Schum-pert’s acute care services occurred in 2013. The complaint does not date the other acquisitions.
Third, throughout this same period, Willis-Knighton never accepted Vantage’s repeated offers to include Willis-Knighton in Vantage’s Tier-1 network. Id. at 15-16. According to Vantage, it has unsuccessfully tried to contract with Willis-Knighton for fifteen years. Id. Those attempts were apparently fruitless because Willis-Knighton either was unwilling to engage with Vantage or was willing to engage but only under terms — 90% reimbursement of Willis-Knighton’s charges — that Vantage saw as “completely uneconomic for any health plan, and would not allow it to compete effectively in virtually any market.”
Fourth, according to Vantage, the effect of these combined Willis-Knighton efforts
2. Present and Future Conduct
The second set of antitrust claims revolve around present and future conduct. Vantage and BRFHH Shreveport assert that a new joint venture .to open clinics located at Willis-Knighton facilities but staffed by LSU physicians — the same LSU physicians who staff University Hospital— constitutes an illegal combination under section 1 of the Sherman Act, both an illegal monopoly and an illegal attempted monopoly under section 2 of the Sherman Act, and an illegal merger under section 7 of the Clayton Act.
In March of 2015, Willis-Knighton and LSU’s medical school in Shreveport signed a series of agreements governing the operation of several new clinics providing care in as many as eleven specialty or subspe-cialty fields of medicine. |d. at 27; Record Documents 24-6 to 24-15, 30-6, and 42. According to the terms of these agreements, LSU would supply the physicians for the clinics and Willis-Knighton would supply the facilities and remaining staff. Record Documents 24-6 to 24-15, 30-6, 42.
The Plaintiffs’ description of control over the clinics goes further, placing Wills-Knighton at the center of both business and medical decision making — to the point that LSU physicians involved in the clinics “would effectively be working for Willis-Knighton.” Record Document 1, pp. 23-24. According to, the Plaintiffs, Willis-Knigh-ton will supervise physician performance-giving it more influence over physician referrals — and control billing — meaning the clinics will not accept coverage by managed care providers like Vantage without substantially increasing its charges. Id. at 23-24, 28, 46-47. Plaintiffs also assert that the clinics will primarily treat commercially insured patients. Id. at 24.
Given this alleged level of control and the assumption that more time worked by LSU physicians at the new joint clinics means less time worked at University Health, Plaintiffs believe that by design these clinics will shift the treatment of all of University Health’s commercially insured patients from University Health facilities to Willis-Knighton facilities. Id. Plaintiffs thus allege that Willis-Knighton is in effect attempting to acquire the commercially ‘ insured business of BRFHH Shreveport. Id. at 2. Willis-Knighton would accomplish this coup not only by shifting
Inversely, the migration of commercially insured patients from University Health to Willis-Knighton would significantly increase Willis-Knighton’s market share in the Shreveport area, according to the Plaintiffs. Id. at 47-51. Were the new clinics to siphon away all of University Health’s commercially insured care, “Willis-Knighton’s 75% share in the relevant hospital market will increase to even higher levels, near 90%.” Id. at 4. Among some of the specialties identified in the clinic agreements, a total shift in care to the clinics would result in Willis-Knighton’s share of the commercially insured market increasing to 50% in Otorhinolaryngology (ENT), 58% in hematology/oncology, 80% in neurology, 70% in Ob/Gyn, and 65% in general pediatrics. Id. at 55.
The new clinics would also allegedly injure Vantage. Id. at 67-69. Because University Health is currently in Vantage subscribers’ Tier-1 network but Willis-Knighton is not, Vantage contends that a migration of commercially insured patients from University Health to Willis-Knighton will be followed by an equivalent loss of Vantage subscribers. Id. at 5, 18, 58, 67-69. This is so allegedly because in. the past, whenever a physician under contract with Vantage joined the Willis-Knighton Physician Network, that contract was immediately .terminated. Id. at 58. Vantage also alleges that in the past whenever a LSU physician in other regions of the state joined a clinic operated by a provider with whom Vantage does not have a relationship, that physician stops accepting Vantage coverage. Id. Thus, because LSU physicians. allegedly, represent more than half of the physicians in Vantage’s Shreveport, area network, the loss of those pa.tients would, “effectively shut Vantage out of the market in the Shreveport Area.” Id. at 67. Vantage believes this loss would be irreparable. Id. at 69.
D. Procedural History
After limited initial discovery, Plaintiffs moved to preliminarily enjoin the Willis-Knighton/LSU clinics, Record Document 24, and Willis-Knighton moved to dismiss all claims against them soon thereafter, Record Document 30. The Court held a hearing to address the parties’ motions. Record Document 83. Ruling from the bench, the Court denied the Plaintiffs’ Motion for Preliminary Injunction and denied Willis-Knighton’s Motion To Dismiss on all but one ground. Record Document 83, p. 2. With respect Vantage’s section 2 claims, the Court declined to rule on dismissal and instead ordered additional briefing from both parties. Id. After thorough briefing from the parties, see Record Documents 89, 90, 93, and 97, the question now ripe before the Court is whether Vantage’s section 2 claims should be dismissed pursuant to Federal Rule of Civil Procedure 12(b)(6).
Willis-Knighton argues that there are three principal reasons to dismiss Vantage’s claims. First, Vantage has not, according to Willis-Knighton, alleged a cognizable theory of anticompetitive conduct,
II. Dismissal Pursuant to Rule 12(b)(6)
To survive a challenge under Rule 12(b)(6), “a complaint must contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its facé.’ ” Ashcroft v. Iqbal,
A claim is facially plausible when a plaintiff pleads factual content that permits the court to reasonably infer a defendant is liable for the alleged misconduct. Iqbal,
III. Discussion
A. Failure To Plead Anticompetitive Conduct Under Section 2 of the Sherman Act
Willis-Knighton argues that Vantage fails to plead anticompetitive conduct, an element of a monopolization claim asserted pursuant to section 2 of the Sherman Act. Record Document 90, 4-8. A defendant is liable for monopolization under section 2 where it (1) possesses monopoly power and (2) achieves or maintains its monopoly power through anticompetitive conduct.
Vantage argues that by alleging that Willis-Knighton has acquired (and is attempting to acquire) competing healthcare providers, has used punitive non-compete contracts with, its physicians, and has restricted patient referrals-to other Willis-
1. Acquisitions
In general, Willis-Knighton argues that none of the conduct that Vantage claims is anticompetitive — the acquisitions, the non-competes, the referrals — can be anticom-petitive because in the Fifth Circuit, conduct is anticompetitive under section 2 only where it is economically irrational for the defendant and here Willis-Knighton had a rational business purpose for all of its challenged actions: growing its business. See id.; Record Document 90, pp. 9-10.
In Stearns, a manufacturer of airport-to-airplane boarding bridges sued a rival manufacturer for monopolization under section 2 of the Sherman Act. Id. at 520-21. Stearns, the plaintiff manufacturer, alleged in relevant part that its competitor, FMC, illegally gained and maintained its monopoly through exclusionary manipulation of municipal bids. Specifically, Stearns alleged that FMC illegally manipulated the airport competitive bid process through four strategies:
First, FMC was to attempt to convince municipalities that they should avoid competitive bidding and strike a purchase agreement with FMC directly — so called “sole-sourcing.” Second, if bidding appeared inevitable, FMC should strive to drive the criteria for the award away from price alone by requesting various product features be weighted against cost in the final calculation of the best bid. Third, efforts were to be made to insure that the specifications adopted by a municipality were tailored to fit FMC’s product and exclude Stearns. Lastly, FMC would “induce complexities in the bidding process” by suggesting certain certifications and restrictions be added that worked to the detriment of Stearns.
Id. at 522. The Fifth Circuit held that these strategies did not amount to anti-competitive conduct'for the purposes of a section 2 monopolization claim. Id. at 527. The court found that the test for determining when conduct becomes anticompetitive
Vantage argues that Stearns notwithstanding, the allegations of Willis-Knigh-ton acquiring competitors is a viable theory of anticompetitive conduct because courts — including the Supreme Court— recognize horizontal acquisitions as anti-competitive conduct. Record Document 89, pp. 13-14. The Supreme Court has established that acquiring a viable competitor constitutes anticompetitive conduct under section 2. See Grinnell,
Courts continue to hold that acquisitions can give rise to anticompetitive conduct for the purposes of a section 2 claim. See Behrend v. Comcast Corp., No. CIV.A. 03-6604,
For three reasons, Willis-Knighton argues that Grinnell and its progeny do not support a finding that the acquisitions challenged in this lawsuit are anticompeti-tive under section 2.
First, as a threshold issue, Willis-Knigh-ton argues that the label “acquisition” mis-characterizes its past conduct. According to Willis-Knighton, the complaint only pleads that it has hired talent from its rivals, not that it has acquired them. Record Document 90, pp. 6-8. And whether hiring talent from a rival is anticompetitive under section 2 is governed by a standard that is far more stringent than the one set forth in Grinnell. Vantage for its part asserts that the complaint alleges more than the mere hiring of talent. The complaint, according to Vantage, alleges that hiring talent from a target provider is but one initial step Willis-Knighton takes in accomplishing its ultimate aim of acquiring the target provider.
The question then becomes how courts distinguish an acquisition from hiring talent for the purposes of assessing section 2 anticompetitive conduct. Unfortunately, neither the parties nor the Court have been able to find any law that draws this distinction. But the law in the Fifth Circuit is that the hiring of rival talent, even if it strengthens a monopolist and weakens a competitor, is generally not anticompetitive. Taylor Pub. Co. v. Jostens, Inc.,
Taylor Publishing governs any acquisition alleged by the Plaintiffs in which the target provider fails because Willis-Knigh-ton hires away its physicians but otherwise does not involve Willis-Knighton acquiring assets of the target provider before it fails. See id. at 471, 480-81. The acquisitions in the complaint that meet these criteria are the acquisitions of Bossier Medical Center,
And with respect to these four alleged acquisitions, Vantage has pleaded no facts to support either element of anticompetitive hiring under Taylor Publishing. The complaint has not alleged that WillisKnighton hired physicians not for its own use but to deny them to any of the target entities. See Taylor Publ’g,
However, the two remaining acquisitions identified in the complaint, the acquisitions of Northwest Louisiana Surgery Hospital and “a previously independent cardiology group,” were apparently outright takeovers and therefore are not governed by Taylor Publishing. For these acquisitions, Willis-Knighton’s second argument against the application of Grinnell is relevant. Willis-Knighton contends that Grinnell does not support a blanket rule that acquisitions establish anticompetitive conduct under section 2. Record Document 97, p. 4. Willis-Knighton emphasizes that in Grinnell, the defendant’s prior acquisitions were not an independent ground for a finding of anticompetitive conduct. See
' This line of argument is unpersuásive for several reasons. First, although not explicit, the language in Grinnell suggests that acquisitions of viable competitors alone may establish the anticompetitive conduct element of a section 2 claim. In its relatively brief discussion of the defendant’s anticompetitive conduct, the Court in Grinnell stated that the defendant’s “monopoly was achieved in large part by unlawful and exclusionary practices. The restrictive agreements ... were one device. Pricing practices ... were another. The acquisitions ... were still another.”
Willis-Knighton’s third argument against the application of Grinnell is that even if the Court does not adopt economic
For Willis-Knighton to prevail on this affirmative defense at the 12(b)(6) stage in the litigation, the complaint alone must prove its requisite elements, i.e., the complaint must .demonstrate as a matter of law (1) nonpretextual, procompetitive justifications for Willis-Knighton’s allegedly anti-competitive actions, which would include its acquisitions, the non-compete agreements, and the restrictive referrals, and (2) that the procompetitive benefit of these actions outweigh their anticompetitive harm. See Microsoft,
The Fifth Circuit has long held that “a claim may [ ] be dismissed if a successful affirmative defense appears clearly on the face of the pleadings.” Clark v. Amoco Prod. Co.,
Because the Plaintiffs’ complaint does not demonstrate as a matter of law either that that there were nonpretextual, procompetitive justifications for WillisKnighton’s allegedly illegal conduct or that the procompetitive benefits of the acquisitions outweighed their anticompetitive harm, Willis-Knighton is not entitled to prevail on a Microsoft procompetitive affirmative defense at this stage in the litigation. Unlike the statute of limitation defense in Kaiser Aluminum, but like the state action doctrine defense in Airline Car Rental, the procompetitive defense that
Therefore, Willis-Knighton’s alleged acquisitions of Northwest Louisiana Surgery Hospital and “a previously independent cardiology group” constitute anti-competitive conduct under section 2 of the Sherman Act. See Grinnell,
2. Non-Compete Agreements and Control of Referrals
Vantage also asserts that its allegations of Willis-Khighton’s non-compete agreements with its physicians and its control of physician referrals are anticompetitive under section 2 of the Sherman Act. Vantage, however, has offered no authority specifically holding or suggesting that non-compete agreements or control of physician referrals are anticompetitive under section 2. Absent any conflicting authority, the non-competes and the control of referrals are anticompetitive if they lacked competition on the merits. See Stearns,
Willis-Knighton has a rational business purpose for both the non-compete agreements and its control of referrals. See id. at 524. As previously stated, Willis-Knigh-ton argues that its rational business purpose for both of these actions was , the same: to treat more patients. The complaint alleges nothing to contradict Willis-Knighton’s argument that the purpose and the effect of the non-compete agreements and the restriction of referrals was to treat more patients. There is no allegation, for
The other two, less important, factors under Stearns point in different directions. Neither party has . argued that these acts may violate Section 1 of the Sherman Act. See id. at 522-23. On the other hand, these acts were done without the participation of consumers, i.e., patients. See id at 523. On the whole, then, the strict application of Stearns to the allegations of Willis-Knigh-ton’s non-compete agreements and control of physicians referrals shows that they are not anticompetitive under section 2 of the Sherman Act and therefore do not give rise to a claim of monopolization or attempted monopolization under the Sherman Act.
For the reasons stated above, the Court finds that Vantage has plead anticompeti-tive conduct with respect to the acquisitions of Northwest Louisiana Surgery Hospital and the cardiology group listed in the complaint. The Court therefore DENIES Willis-Knighton’s motion to dismiss for failure to plead anticompetitive conduct.
B. Antitrust Injury
Willis-Knighton argues that Vantage has not suffered antitrust injury. Antitrust injury is a component of antitrust standing, Antitrust- standing,' in turn, is a judicially-created set of threshold requirements that a private plaintiff must show before a court can entertain its antitrust claims. See Associated Gen. Contractors of Cal., Inc. v. Cal. State Council of Carpenters (“AGC”),
The second component of antitrust standing, anitrust injury, requires that a plaintiffs injury is “of the type the antitrust laws were intended to prevent and ... flows from that which makes the defendant’s acts unlawful.” Brunswick Corp. v. Pueblo Bowl-O-Mat, Inc.,
Vantage asserts that it has suffered antitrust injury because Willis-Knighton’s refusal to contract with it (its alleged injury) was made possible by the monopoly power Willis-Knighton achieved through its anti-competitive acquisitions (the anticompeti-tive effect of the specific practice that allegedly violates antitrust law). See Record Document 89, p. 25.
For monopolization claims, refusals to contract with the plaintiff do not constitute antitrust injury because the injury suffered by the plaintiff is one that could have just as easily occurred in the absence of monopoly power. See Jebaco,
Similarly, in Port Dock, the Second Circuit held that a distributer did not suffer antitrust injury from a . manufacturer where the complaint alleged that the man
In Fischer, the Eighth Circuit held that a regional airline did not suffer antitrust injury from a national airline where the complaint alleged that, the national airline monopolized the market for air service to a particular destination and the regional airline was injured because the national airline, post-monopolization, terminated its service contract-with the regional airline at that destination. Id. at 600. The regional airline plaintiff, Fischer, was the exclusive carrier for all of Northwest Airlines’s regional flights originating in Detroit under a contract that either party could terminate with or without cause. Id. at 595-96. Northwest then acquired Republic Airlines, another national carrier at the time, which had its own regional airline partner, Simmons Airlines, exclusively servicing its regional flights through Detroit. Id. at 596. That contract was not terminable at will. Id. After considerable effort to mediate the inevitable conflicting demands of Fischer and Simmons, Northwest terminated Fischer, its Detroit carrier. Id. at 597. Fischer sued Northwest under Section 2 for monopolizing the Detroit market, of which Northwest had gained a 75% share though its acquisition of Republic. Id The court reasoned that Fischer had not plead antitrust injury because its injury, the termination of its Detroit service agreement, had not been caused by the anticompetitive effects of the Republic acquisition, such as
In Serpa, the First Circuit held that a distributer did not suffer antitrust injury from a manufacturer where the complaint alleged that the manufacturer illegally monopolized the manufacturing level through acquisitions and the retailer was injured because the manufacturer, post-monopolization, terminated their distribution arrangement. See
Vantage argues that almost all of these cases are distinguishable from its claims. Record Document 89, pp. 25-59. Vantage distinguished the position and nature of the plaintiff in Jebaco, a lessor standing above the defendants in the stream of commerce, from itself, a customer standing below Willis-Knighton in the healthcare stream of commerce. Id. at 28 (emphasizing that the consumer is the intended beneficiary under antitrust law). This distinction, while in itself true, does not disturb Jebaco’s reasoning of the defendant’s termination of the lease contract could have been done just as easily regardless of its antitrust violations. See
Vantage’s reasoning here is faulty for two reasons. First, it misses the logic underlying the holdings in Fischer and its cousin cases, which is that in all instances, a firm can terminate a contractual relationship (or refuse to start a contractual relationship) just as easily without market power as it can with market power. Second, it seems to recharacterize Vantage’s injury not as Willis-Knighton’s refusal to deal, but the shrinking pool of providers available to contract with Vantage. This is the consequence of Vantage’s injury, not its injury in itself. If Willis-Knighton had agreed to contract with Vantage, Vantage would be unaffected by the shrinking pool of non-Willis-Knighton providers in the Shreveport area.
Vantage also argues that Christian Schmidt Brewing v. G. Heileman Brewing
Thus, to the extent that Vantage has alleged that it was injured by WillisKnighton refusing to contract with it, Vantage has not alleged anticompetitive conduct. See, e.g., Jebaco,
However, to the extent that Vantage has alleged that it was injured because Willis-Knighton demanded exorbitant reimbursement rates, it has plead antitrust injury. Unlike the injuries alleged by the plaintiff in Port Dock and the like, Willis-Knighton requiring high reimbursement rates is the type of injury that flows from Willis-Knighton’s market power because Willis-Knighton could not have demanded what were effectively higher prices without market power. See Port Dock,
Based on the above discussion, the Court therefore DENIES Willis-Knigh-ton’s motion to dismiss based on Vantage’s lack of antitrust injury.
C. Insufficient Detail Under Iqbal and Twombly
Finally, Willis-Knighton argues that all of Vantage’s claims must be dismissed because they lack the specificity required under Twombly and Iqbal. Record Document 90, pp. 21-27. Under Twombly, a complaint must allege facts sufficient “to raise a right to relief above the speculative level” so that a right to relief “is plausible on its face.”
1. Whether Vantage Plausibly Alleged that LSU Physicians Working at the Joint Clinics Will Drop Vantage
Willis-Knighton argues that Vantage’s allegations about Willis-Knighton’s involvement with LSU fail to state a claim under Twombly because they are conclusory with respect to how Vantage would be injured by LSU physicians treating patients at Willis-Knighton clinics. Record Document 90, pp. 21-24.
Vantage’s complaint must allege facts that, either directly or inferentially, plausibly show that Vantage has- been injured. See Twombly,
Willis-Knighton cites two cases to support its argument. Corr Wireless Commc’ns, L.L.C. v. AT&T, Inc., is illustrative of the level of specificity required to plead injury. See
The second case cited by Willis-Knigh-ton, In re Elevator Antitrust Litigation, shows the limits to which an antitrust plaintiff can rely on conduct by the defendant in one context to plausibly plead that the defendant has engaged in the same conduct in another context. See
Vantage’s allegation of how physicians migrating from University Health to LSU clinics would harm Vantage is distinguishable from the allegation of harm in Corr Wireless. Unlike the plaintiff in Corr Wireless, who was unable to produce any allegations of present conduct by the defendant that served as the basis for its assertion that the defendant would injure it in the future, Vantage has described with some detail how Willis-Knighton is presently engaged in a joint clinic with LSU physicians working at University Health. And Vantage’s reliance on prior conduct by Willis-Knighton and LSU to establish that LSU physicians working at the joint clinics will drop Vantage is distinguishable from the plaintiff’s reliance in Elevator Antitrust on the defendant’s antitrust violations in Europe to establish that the defendant violated antitrust laws in the United States. Unlike the plaintiff in Elevator Antitrust, who was unable to provide any link explaining why the antitrust violations by the defendants in one market
Amid this discussion, WillisKnighton also inserts an Article III standing rationale for its arguments that Vantage’s claims of injury are too speculative. See Record Document 90, p. 23, and 97, p. 8. Vantage does not directly address this argument. Article III standing requires in part that the plaintiff demonstrate it has suffered injury in fact, which is “an invasion of a legally protected interest that is (a) concrete and particularized and (b) actual or imminent, not conjectural or hypothetical.” Lujan v. Defenders of Wildlife,
To establish standing for future injury, a plaintiff needs to credibly explain how present facts create a realistic threat of future injury. See City of Los Angeles v. Lyons,
Similarly, in United Transportation Union, the D.C. Circuit held that a union plaintiff failed to plead Article III injury where it alleged that the ICC’s approval of interlocking directorates of railroad companies would injure the workers of the affected railroad companies.
Vantage has credibly explained how present facts create a realistic threat of future injury. Unlike the plaintiffs claims in Lyons and United' Transportation Union, which provided no information to link present facts with future injury, Vantage has, as discussed above, provided facts explaining why LSU physicians practicing at the LSU/Willis-Knighton clinics would result in those physicians leaving Vantage’s Tier-1 network. See Lyons,
2. Whether Vantage Plausibly Stated a Claim for Past Antitrust Violations by Willis-Knighton
Next, Willis-Knighton argues that Vantage’s allegations about Willis-Knighton’s past conduct fail to state a claim under Twombly because they allege insufficient details about either the prior alleged acquisitions or the relevant markets that Willis-Knighton monopolized/attempted to monopolize. The complaint must plead facts that, either directly or inferentially, plausibly show Willis-Knighton had market power/a dangerous probability of market power and committed acts that, when viewed as a whole, constitute anticompeti-tive conduct.
Specifically, Willis-Knighton argues that the complaint does not plausibly plead market power for Willis-Knighton’s past conduct because it does not provide any past market shares for WillisKnighton. To demonstrate monopoly power, a complaint must specify the specific product and geographic market which defendant is alleged to have monopolized. Rockbit Indus. U.S.A., Inc. v. Baker Hughes, Inc.,
Willis-Knighton also specifically argues that the complaint provides insufficient detail about the past acquisitions, such as their dates, to plausibly plead anticompeti-tive conduct. The Court finds that requiring the complaint to identify the details of every prior acquisition would ask more than Twombly- demands. Instead, the complaint must plead facts that, when viewed together, make anticompetitive conduct plausible. See Twombly,
IV. Conclusion
For all of the foregoing reasons, the Defendant’s motion to dismiss [Record Document 30] is DENIED.
Notes
. The complaint does not specify whether those gains occurred within the Shreveport area or whether Willis-Knighton enjoyed those gains in all markets it serves. Willis-Knighton also operates a hospital in Arkansas. Record Document, p. 9.
. Filings subsequent to the complaint, however, have shed additional light on some of
. Vantage argues that a more customary rate would be 50% of charges that are set by Medicare’s Diagnostic Related Group system, not by the hospital. Record Document 1, p. 16. Plaintiffs also assert that "Willis-Knigh-ton’s reimbursement rates are from 50% to several hundred percent higher than those at UH-Shreveport.” Id. at 14.
. The complaint also initially alleged that Willis-Knighton was planning an outright takeover of University Hospital. Record Document 1, p. 23-30. But Plaintiffs later abandoned this theory. Record Document 83, p. 2.
. Vantage has alleged attempted monopolization, another cause of action under section 2 of the Sherman Act. See 15 U.S.C. § 2 (2012); Spectrum Sports, Inc. v. McQuillan,
. Courts also label anticompetitive conduct exclusionary conduct, predatory conduct, and improper conduct. See Taylor Pub. Co. v. Jostens, Inc.,
. See Aspen Skiing Co. v. Aspen Highlands Skiing Corp.,
.See also United States v. Aluminum Co.,
. Notably, Vantage does not contend that Willis-Knighton's "effective refusal to deal” with it constituted anticompetitive conduct. A refusal to deal may qualify as anticompetitive conduct, but only under limited circumstances. See Aspen Skiing,
. The separate analysis of these three groups of conduct is not impermissible "compartmentalizing” of allegedly anticompetitive conduct, See Continental Ore Co. v. Union Carbide & Carbon Corp.,
. See also id. at 523 (“Generally, a finding of exclusionary conduct requires some sign that the monopolist engaged in behavior that— examined without reference to its effects on competitors — is economically irrational.”).
. Although the court stated that this determination would be upset if there were evidence that airports’ decision making had been coopted or coerced, id. at 526 (“Bribery and threats are not competition on the merits.”), the court found that Stearns had failed to introduce any such evidence. IcL
. Vantage also asserts that Electronic Data Systems v. Computer Associates,
. The Court notes that while a filing subsequent to the complaint indicates that Willis-Knighton "purchased" Bossier Medical Center for $3.7 million in 2012, Record Document 24-30, that filing was not an exhibit attached to the complaint and therefore the Court may not consider it in a 12(b)(6) motion to dismiss.
. Courts no longer consider intrabrand restrictions on competition enforced by the parent company to be anticompetitive. See Cop
. The other cases on which Willis-Knighton relies to support its affirmative defense argument, Port Dock,
In Port Dock, the Second Circuit held that a section 2 monopolization claim alleging a vertical acquisition accompanied by a refusal to deal should be dismissed under Rule 12(b)(6) because it failed to allege anticompet-itive conduct.
In Morris Communications, a publisher sued the Professional Golf Association for monopolizing the publication of real-time golf scores. Id. at 1290-93. The Eleventh Circuit affirmed summary judgment dismissal of the publisher’s claim, holding that the defendant had demonstrated, as a defense, that its conduct had a nonpretextual, valid business justification. Id. at 1297-98. Because the court in Morris Commc'ns affirmed dismissal of the publisher’s monopolization claim on summary judgment, rather than under Rule 12(b)(6), Morris Commc'ns does not support Willis-Knighton’s argument that it is entitled to prevail on its affirmative defense of a non-pretextual, procompetitive justification for its allegedly illegal acquisitions. See id. at 1292.
. While not dispositive of market power, market share often serves as an imperfect proxy for market power. See Domed Stadium Hotel, Inc. v. Holiday Inns, Inc.,
. Jebaco also alleged it was injured because the defendants deprived it of an opportunity to compete for the casino bid. Id. The court dismissed this claim as failing to allege antitrust injury, albeit for reasons not relevant to Vantage’s claims. See id. at 321.
. The court also reasoned that there was no antitrust injury because the termination of the lease was the .product of “downstream” allegedly anticompetitive conduct. Id. at 320. The court found that courts generally do not recognize antitrust injury for the termination of a contract or lease that is caused -by "downstream” anticompetitive conduct, i.e., conduct by entities that are closer to the consumer in the stream of commerce than the plaintiff. See id (citing 2 P. Areeda & H. Ho-venkamp, Antitrust Law, 350(f-g), at 422-23 (2d ed. 2000) (“When a downstream firm merely substitutes one supplier for another, there is certainly injury-in-fact to the terminated supplier, but there is rarely antitrust injury.”)). Applying this rule to Jebaco’s claims, the court reasoned that Jebaco had not suffered antitrust injury because it alleged that its lease (assignment) was terminated as a result of anticompetitive acts by casinos operators, which are farther "downstream” in the market for gambling than Jebaco as lessor. Id.
. The court also found "tentative evidence" that these adverse effects would actually occur. Id. at 1357.
. The elements of Vantage’s monopolization claim based on Willis-Knighton's past conduct are (1) Willis-Knighton possessed market power in the relevant market and (2) Willis-Knighton engaged in anticompetitive conduct. See Stearns,
